Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
11.81
+0.48 (4.24%)
Aug 13, 2025, 4:00 PM - Market closed
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $307.08 million as of August 14, 2025. Its market cap has decreased by -1.35% in one year.
Market Cap
307.08M
Enterprise Value
157.51M
1-Year Change
-1.35%
Ranking
Category
Stock Price
$11.81
Market Cap Chart
Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $307.08M, an increase of 29.68%. That is a compound annual growth rate of 2.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 294.60M | -35.28% |
| Dec 31, 2024 | 455.20M | 325.42% |
| Dec 29, 2023 | 107.00M | -38.11% |
| Dec 30, 2022 | 172.90M | -54.54% |
| Dec 31, 2021 | 380.30M | 16.19% |
| Dec 31, 2020 | 327.30M | 185.35% |
| Dec 31, 2019 | 114.70M | 92.13% |
| Dec 31, 2018 | 59.70M | -72.75% |
| Dec 29, 2017 | 219.10M | -29.78% |
| Dec 30, 2016 | 312.00M | 31.76% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 588.02B |
| Johnson & Johnson | 419.15B |
| AbbVie | 355.29B |
| UnitedHealth Group | 245.55B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.96B |
| Novo Nordisk | 223.00B |